Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin-induced Hearing Loss”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableUnknownNCT00578760
What this trial is testing

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Who this might be right for
Hearing LossOtotoxicity
University Health Network, Toronto 110
Testing effectiveness (Phase 2)Looking for participantsNCT04915183
What this trial is testing

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Who this might be right for
Hearing LossHead and Neck Cancer
National Institute on Deafness and Other Communication Disorders (NIDCD) 224
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Not applicableStudy completedNCT02099786
What this trial is testing

Randomized Trial Comparison of Ototoxicity Monitoring Programs

Who this might be right for
Cisplatin OtotoxicityHearing Loss
VA Office of Research and Development 47
Early research (Phase 1)Study completedNCT02094625
What this trial is testing

NAC to Prevent Cisplatin-induced Hearing Loss

Who this might be right for
Neuroectodermal Tumors, PrimitiveLiver NeoplasmsOsteosarcoma+1 more
Children's Hospital Los Angeles 52
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Not applicableNot Yet RecruitingNCT05946577
What this trial is testing

Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study

Who this might be right for
Head CancerNeck Cancer
Assistance Publique - Hôpitaux de Paris 140
Testing effectiveness (Phase 2)Study completedNCT01139281
What this trial is testing

The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans

Who this might be right for
OtotoxicityHearing Loss
University of Brasilia 15
Testing effectiveness (Phase 2)Study completedNCT05628233
What this trial is testing

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Who this might be right for
Hearing Loss Ototoxic
Sensorion 48
Not applicableLooking for participantsNCT06551857
What this trial is testing

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Who this might be right for
CancerHearing Loss OtotoxicCognitive Decline+1 more
Turku University Hospital 250
Not applicableStudy completedNCT03400709
What this trial is testing

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Who this might be right for
Cisplatin Adverse ReactionHearing Loss Ototoxic
Hospital San Juan de Dios, Santiago 45
Testing effectiveness (Phase 2)Looking for participantsNCT05129748
What this trial is testing

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 92
Early research (Phase 1)Looking for participantsNCT07218913
What this trial is testing

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Who this might be right for
Hearing LossMetastatic Malignant Germ Cell TumorMetastatic Malignant Nongerminomatous Germ Cell Tumor+4 more
City of Hope Medical Center 44
Not applicableAvailableNCT04132882
What this trial is testing

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

Who this might be right for
Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma
TRPHARM
Large-scale testing (Phase 3)Looking for participantsNCT07281508
What this trial is testing

Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial

Who this might be right for
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT02997189
What this trial is testing

Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss

Who this might be right for
Cisplatin Induced Hearing Loss
Otonomy, Inc. 12
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Not applicableWithdrawnNCT02382068
What this trial is testing

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Who this might be right for
Malignant NeoplasmOtotoxicity
Aaron Moberly
Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Load More Results